During the G1-S checkpoint, CDK4/6 activation by the AR axis contributes to cancer cell proliferation; among the mechanisms of resistance to NHA, the upregulation of cyclin D1 (whose association with CDK4/6 is crucial for the transition from G1 to S phase) was described [84]. The gene discussed is AR; the disease is cancer.